# Lexia LLC – FDA Inspection, Mar 7, 2019

Source: https://www.keypedia.com/records/fda_inspections/lexia-llc/7fa9b4c4-a638-40ec-9a0d-63849b40bcf5
Source feed: FDA_Inspections

> FDA inspection 1081647 of Lexia LLC, March 07, 2019. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081647
- Company Name: Lexia LLC
- Inspection Date: 2019-03-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1284722 - 2025-09-29](https://www.keypedia.com/records/fda_inspections/lexia-llc/1c42bb59-a8ac-4aa9-9303-f20790ec2e7f)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/june-p-page/3b1ffc71-ce2e-47f5-aefe-87fd5eebc792)

Company: https://www.keypedia.com/companies/lexia-llc/7f29fe6a-68bf-4b1d-906d-4d1c093efde4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
